(MedPage Today) — Among 10 patients with various autoimmune diseases who had failed numerous conventional treatments, nine saw substantial improvement with the multiple myeloma drug teclistamab (Tecvayli), researchers said.
Three of the patients…
Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/117966
Author :
Publish date : 2025-10-15 21:07:00
Copyright for syndicated content belongs to the linked Source.
